Vienna - Delayed Quote EUR

ResMed Inc. (RMD.VI)

216.00
-1.50
(-0.69%)
At close: 5:32:30 PM GMT+2
Loading Chart for RMD.VI
  • Previous Close 217.50
  • Open 216.40
  • Bid 215.60 x --
  • Ask 216.30 x --
  • Day's Range 216.00 - 216.50
  • 52 Week Range 168.95 - 248.60
  • Volume 0
  • Avg. Volume 3
  • Market Cap (intraday) 31.671B
  • Beta (5Y Monthly) 0.78
  • PE Ratio (TTM) 27.52
  • EPS (TTM) 7.85
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 1.87 (0.86%)
  • Ex-Dividend Date May 8, 2025
  • 1y Target Est --

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

www.resmed.co.in

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: RMD.VI

View More

Performance Overview: RMD.VI

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RMD.VI
2.28%
S&P 500 (^GSPC)
3.77%

1-Year Return

RMD.VI
9.09%
S&P 500 (^GSPC)
8.55%

3-Year Return

RMD.VI
20.74%
S&P 500 (^GSPC)
41.81%

5-Year Return

RMD.VI
50.26%
S&P 500 (^GSPC)
93.18%

Compare To: RMD.VI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RMD.VI

View More

Valuation Measures

As of 5/8/2025
  • Market Cap

    31.53B

  • Enterprise Value

    31.45B

  • Trailing P/E

    27.68

  • Forward P/E

    23.70

  • PEG Ratio (5yr expected)

    1.47

  • Price/Sales (ttm)

    7.24

  • Price/Book (mrq)

    6.52

  • Enterprise Value/Revenue

    7.08

  • Enterprise Value/EBITDA

    20.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.15%

  • Return on Assets (ttm)

    14.01%

  • Return on Equity (ttm)

    25.81%

  • Revenue (ttm)

    5.02B

  • Net Income Avi to Common (ttm)

    1.31B

  • Diluted EPS (ttm)

    7.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    944.84M

  • Total Debt/Equity (mrq)

    15.14%

  • Levered Free Cash Flow (ttm)

    1.2B

Research Analysis: RMD.VI

View More

People Also Watch